Paul D. Leeson

Computational Theory and Mathematics · 1999–2015

A researcher in the Science corpus: 5 papers; trusts 1 researcher and is trusted by 7 researchers here, as inferred from the citation graph.

Subfields

Whom Paul D. Leeson trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

  1. Christopher A. Lipinski
  2. M. Hann
  3. Tudor I. Oprea

Who trusts Paul D. Leeson overall

  1. Michael J. Waring
  2. John A. Arnott
  3. M. Hann
  4. Ye Fang
  5. A. Hopkins
  6. Timothy J. Ritchie
  7. Gisbert Schneider
  8. E. Putin
  9. Peter Willett
  10. S. Planey

Papers from Paul D. Leeson's perspective

Ordered by how strongly the researchers Paul D. Leeson trusts endorse each paper. Same corpus, a different order for every researcher.

  1. Global mapping of pharmacological space
  2. A bioavailability score. (Journal of Medicinal Chemistry)
  3. Molecular properties that influence the oral bioavailability of drug candidates. (Journal of Medicinal Chemistry)
  4. Is There a Difference between Leads and Drugs? A Historical Perspective (Journal of chemical information and computer sciences)
  5. Lead- and drug-like compounds: the rule-of-five revolution. (Drug Discovery Today : Technologies)
  6. Structure-based maximal affinity model predicts small-molecule druggability (Nature Biotechnology)
  7. Analysis of Pharmacology Data and the Prediction of Adverse Drug Reactions and Off‐Target Effects from Chemical Structure (ChemMedChem)
  8. The druggable genome (Nature reviews. Drug discovery)
  9. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings.
  10. The impact of aromatic ring count on compound developability--are too many aromatic rings a liability in drug design? (Drug Discovery Today)

Their papers